GLP-1 Treatment: How BIA Helps to Prevent Silent Muscle Loss
I. The Mechanisms of Action of GLP-1 For several years, GLP-1 analogues have been increasingly used in the management of patients with type II diabetes or obesity, with a growing number of molecules on the market. GLP-1, for Glucagon-Like Peptide-1, is a molecule naturally and continuously secreted by cells in the intestine, with secretion peaks […]
Multi-Frequency Bioimpedance From Aminogram: A Key Tool for Public Health
Introduction Multi-frequency bioimpedance has emerged as a revolutionary technology in the field of public health, offering a precise and non-invasive evaluation of body composition. Aminogram, a leading company in the development of multi-frequency bioimpedance devices, has designed tools that not only improve prevention and diagnosis but also optimize the monitoring of medical, surgical, pharmacological, dietary, […]
GLP-1 Agonists in the Treatment of Obesity: Benefits, Risks, and the Role of Bioimpedance
Gildardo Uribe GilND- MgSC, Phd (c) en SP Obesity is a complex condition that affects millions of people worldwide, with WHO projections indicating that approximately 4 billion adults will be living with overweight or obesity by 2030. In addition to metabolic and cardiovascular impacts, excess body fat is associated with multiple comorbidities that affect quality […]
Obesity and Physical Activity: Benefits and Management Modalities
Learn how physical activity, combining aerobic and resistance exercises, improves body composition and supports effective obesity management.
Obesity and Sarcopenia: The Importance of Muscle Mass in Management
According to a recent expert consensus¹, obesity is defined as a condition characterized by a body mass index (BMI) greater than 30 kg/m², combined with excess fat mass that leads to clinical complications impairing the patient’s health. From a pathophysiological perspective, this excess fat mass causes low-grade systemic inflammation due to the production of pro-inflammatory […]
New Approach to Obesity: BIA as the Key to Diagnosis and Monitoring
Introduction to the new approach to obesity: Results of an expert commission On January 14, 2025, the results of a commission composed of medical specialists and researchers were published in The Lancet Diabetology & Endocrinology. Their goal was to rethink the framework for understanding and managing obesity¹. Globally, the World Health Organization reported that in […]